UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Season of birth, childhood asthma and allergy in a nationwide cohort—Mediation through lower respiratory infections

Clinical and experimental allergy, 2020-02, Vol.50 (2), p.222-230

2020

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

Acta oncologica, 2024-04, Vol.63 (1), p.164-168

2024

Volltextzugriff (PDF)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Blood cancer journal (New York), 2021, Vol.11 (1), p.9-9, Article 9

2021

Volltextzugriff (PDF)

No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study

Breast cancer research : BCR, 2018-11, Vol.20 (1), p.142-142, Article 142

2018

Volltextzugriff (PDF)

Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients

Clinical and translational radiation oncology, 2024-05, Vol.46, p.100785-100785, Article 100785

2024

Volltextzugriff (PDF)

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

HemaSphere, 2023-08, Vol.7 (S3), p.e91359ec-n/a

2023

Volltextzugriff (PDF)

Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH

BMC research notes, 2023-10, Vol.16 (1), p.1-265, Article 265

2023

Volltextzugriff (PDF)

Increased healthcare use up to 10 years among relapse‐free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy

American journal of hematology, 2017-03, Vol.92 (3), p.251-258

2017

Volltextzugriff (PDF)

Infections in patients with mantle cell lymphoma

HemaSphere, 2024-07, Vol.8 (7), p.e121-n/a

2024

Volltextzugriff (PDF)

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project

HemaSphere, 2023-08, Vol.7 (8), p.e928-n/a

2023

Volltextzugriff (PDF)

Survival by First‐line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population‐based Study in Sweden

HemaSphere, 2023-03, Vol.7 (3), p.e838-n/a

2023

Volltextzugriff (PDF)

Are opportunities and threats enough? A development of the labels of strategic issues

Journal of media business studies, 2020-01, Vol.17 (1), p.13-32

Ekberg, Sara

2020

Volltextzugriff (PDF)

Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation

Blood, 2021-11, Vol.138 (Supplement 1), p.1344-1344

2021

Volltextzugriff (PDF)

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients

British journal of haematology, 2022-07, Vol.198 (2), p.267-277

2022

Volltextzugriff (PDF)

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Blood, 2020-11, Vol.136 (Supplement 1), p.38-39

2020

Volltextzugriff (PDF)

Statin use and survival in 16098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

British journal of haematology, 2021-11, Vol.195 (4), p.552-560

2021

Volltextzugriff (PDF)

Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission

British journal of cancer, 2022-11, Vol.127 (9), p.1642-1649

2022

Volltextzugriff (PDF)

Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

British journal of haematology, 2024-09

2024

Volltextzugriff (PDF)

Dog characteristics and future risk of asthma in children growing up with dogs

Scientific reports, 2018-11, Vol.8 (1), p.16899-8, Article 16899

2018

Volltextzugriff (PDF)

Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study

British journal of haematology, 2020-06, Vol.189 (6), p.1083-1092

2020

Volltextzugriff (PDF)

Secondary malignancies among mantle cell lymphoma patients

European journal of cancer (1990), 2023-12, Vol.195, p.113403-113403, Article 113403

2023

Volltextzugriff (PDF)

Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

British journal of haematology, 2021-11, Vol.195 (4), p.552-560

2021

Volltextzugriff (PDF)

Long-Term Survival and Survivorship in Non-Hodgkin Lymphoma Patients in Sweden

Ekberg, Sara

2021

Volltextzugriff (PDF)

Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients

American journal of hematology, 2020-06, Vol.95 (6), p.652-661

2020

Volltextzugriff (PDF)

Fostering growth through business development: Core activities and challenges for micro-firm entrepreneurs

Journal of management & organization, 2017-03, Vol.23 (2), p.167-185

2017

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Season of birth, childhood asthma and allergy in a nationwide cohort—Mediation through lower respiratory infections

Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study

Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH

Increased healthcare use up to 10 years among relapse‐free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy

Infections in patients with mantle cell lymphoma

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project

Survival by First‐line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population‐based Study in Sweden

Are opportunities and threats enough? A development of the labels of strategic issues

Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Statin use and survival in 16098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission

Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Dog characteristics and future risk of asthma in children growing up with dogs

Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study

Secondary malignancies among mantle cell lymphoma patients

Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Long-Term Survival and Survivorship in Non-Hodgkin Lymphoma Patients in Sweden

Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients

Fostering growth through business development: Core activities and challenges for micro-firm entrepreneurs

Suchergebnisse filtern